{"id":"n_vilezli24lm7khpl5twq","seq":9240353,"kind":"article","title":"FDA orders manufacturers to disclose risk of developing eye disease on GLP-1 labels","url":"https://www.wcvb.com/article/fda-orders-manufacturers-to-disclose-risk-of-developing-eye-disease-on-glp-1-labels/74380453","summary":"Dr. Ali Raja, the chair of emergency medicine at Mass General Brigham, said that NAION is a sudden, painless loss of vision, which the FDA announced is now a possible side effect of certain GLP-1s.","published":"2026-11-09T23:01:00Z","seen":"2026-11-09T23:25:02Z","lang":"en","country":"US","source":{"id":"kite-wcvb-com-6be115","name":"wcvb.com","domain":"wcvb.com"},"via":"kite-wcvb-com-6be115","topics":["boston"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"}],"image":"https://kubrick.htvapps.com/vidthumb/aafc5742-4a73-4f71-b5e5-bfb9eaa61128/fce8e099-02bf-48d5-a748-9844748d00ae.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.66,"sentiment":"neutral","tone":-0.4,"political":0.07}